BioMarin Pharmaceutical <BMRN.O>: Barclays Raises Target Price to $111 From $105
BMRN•Related News
Dynatrace plans private placement of $1.25 billion exchangeable senior notes due 2031
DT•
Gold rises on softer dollar, fading Fed hike expectations
GLD•
American Healthcare REIT, Inc. <AHR.N>: BMO raises target price to $65 from $60
AHR•
Cloudastructure Q2 FY26 net loss narrows to $1.7 million; revenue rises 13% to $1.2 million
CSAI•
InspireMD Q2 revenue beats estimates on international demand
NSPR•